Capital Investment Advisory Services’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Hold
0
981
2024
Q2
Hold
0
966
2024
Q1
Hold
0
952
2023
Q4
Hold
0
978
2023
Q3
Sell
-11,002
Closed -$225K 964
2023
Q2
$225K Buy
11,002
+1
+0% +$21 0.02% 432
2023
Q1
$228K Sell
11,001
-649
-6% -$13.6K 0.03% 425
2022
Q4
$246K Buy
11,650
+300
+3% +$6.2K 0.03% 410
2022
Q3
$215K Buy
11,350
+650
+6% +$12.9K 0.03% 418
2022
Q2
$201K Buy
10,700
+1,300
+14% +$24.8K 0.02% 447
2022
Q1
$197K Buy
+9,400
New +$195K 0.02% 495

Other funds holding IBBQ

Capital Investment Advisory Services's IBBQ Position: Q3 2024 in Review

Capital Investment Advisory Services held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q3 2024 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Capital Investment Advisory Services first reported a position in IBBQ in Q1 2022 and has held it in 6 quarters since. The position peaked at $246K in Q4 2022. 22 funds tracked by Wall St. Rank hold IBBQ as of Q3 2024.

  • Capital Investment Advisory Services held 0 shares of Invesco NASDAQ Biotechnology ETF worth $1 as of Q3 2024.
  • Capital Investment Advisory Services left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q3 2024.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q3 2024, its #981 holding.
  • Capital Investment Advisory Services first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2022 and has held it in 6 quarters since.
  • Capital Investment Advisory Services's Invesco NASDAQ Biotechnology ETF position peaked at $246K in Q4 2022.
  • 22 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2024.

Based on Capital Investment Advisory Services's 13F filing for Q3 2024, filed 30 Oct 2024.